Oncotarget is a peer-reviewed and open access medical journal based in the United States. The term Oncotarget includes all cellular functions, molecules, and pathways common in cancer and aging, lymphocytes and neurons, atherosclerosis and neurodegeneration, cancer cells, and microbes. It publishes papers online on a weekly basis. Besides, each issue can be printed on demand. It covers research based on all aspects of oncology. It was established in 2010 and is usually published by Impact Journals.
The journal is indexed and abstracted in Index Medicus, BIOSIS Previews, Science Citation Index Expanded, and Scopus. Oncotarget has a mission of ensuring that scientific results are widely and rapidly available, eliminating the border between specialties. It also focuses on maximizing the impact of research through insightful review, linking different fields of biomedical science to foster the application of clinical and basic science to avoid diseases. The journal has also enhanced exceptional discoveries are shared them widely and what Oncotarget knows.
With a leadership of the most prominent scientist, Oncortaget helps researchers contribute to the progress of science. The success of Oncotarget has prompted the launch of other sections beyond oncology such as Neuroscience, Cell biology, pharmacology, metabolism, Cardiology, Endocrinology among others. Its impact factor is at 5.168, with the ResearchGate data. It is based on the average citation counts from work published in the journal. It has enabled people whose journals are mistakenly rejected by leading journals to submit their papers to them with peer reviews sourced from the other journal and a rebuttal letter and more information click here.
Oncortarget will start publishing two issues per week instead of the one issue they were previously published due to increased demand. Oncotarget is giving alt-metric article reports free. They are doing that to provide a real-time tracking of articles in digital and traditional media channels on Facebook before accruing of traditional citations and Oncotarget lacrosse camp.
Oncotarget editors evaluate the manuscripts based on scientific novelty, merit, presentation and quality of data regardless of the authors’ sexual orientation, race, citizenship, and religious beliefs. Information in the manuscript is only disclosed to the authors, reviewers, and members of the editorial board. Therefore, the information is treated with confidentiality. Peer review is usually obligatory and essential as it helps editors make the right decisions, and they comment to the authors so that they improve on their manuscripts and what Oncotarget knows.